Managing GLP-1 Side Effects: Our Top Tips for Success GLP-1 agonists, like semaglutide and tirzepatide, are groundbreaking treatments for managing type 2 diabetes and obesity
308 Although this tolerant state is initially reversible upon drug withdrawal, representing a resensitization exit route, prolonged persistence under treatment pressure increases the probability of acquiring irreversible genetic alterations, driving an alternative exit toward stable, mutation-driven resistance and tumor relapse
Research-Use-Only Laboratory Material Lyophilized powder supplied in standard laboratory vials
First-in-human testing of a wirelessly controlled drug delivery microchip
The study was approved by the Institutional Review Board of the Johns Hopkins Bloomberg School of Public Health
Ozempic is designed for managing type 2 diabetes, while Wegovy is specifically approved for weight loss